MRNA news, real time MRNA stock news, Moderna news today

News

MRNA

40.51

-3.54%

-1.49

PRESS DIGEST-New York Times business news - February 12

Reuters · 1h ago

Why the FDA Blocked Moderna's New Flu Shot

The Wall Street Journal · 8h ago

Stocks Settle Mixed as Fed Rate Cut Chances Slip

NASDAQ · 11h ago

Moderna Stock Sinks on Vaccine Rejection. Company Is 'Desperately Seeking Clarification.'

Barron‘s · 12h ago

What To Expect From Moderna’s (MRNA) Q4 Earnings

Barchart · 12h ago

FDA Flu Vaccine Rebuff Puts Moderna Respiratory Pipeline Timing In Focus

Simply Wall St · 13h ago

These Stocks Are Today's Movers: Shopify, Moderna, Robinhood, Unity, Vertiv, Generac, Beta Tech, Humana, Micron, and More

Barron‘s · 14h ago

FDA SAYS MODERNA EXPOSED PARTICIPANTS, AGE 65 AND OVER, TO INCREASED RISK OF SEVERE ILLNESS BY GIVING THEM A SUB STANDARD OF CARE AGAINST THE RECOMMENDATION OF FDA CAREER SCIENTISTS - STATEMENT

Reuters · 15h ago

FDA SAYS THE MOST PROTECTIVE FLU SHOTS FOR SENIORS ARE A SUBSET OF HIGH DOSE FLU SHOTS, WHICH WOULD HAVE SERVED AS THE PROPER CONTROL IN THIS STUDY- STATEMENT

Reuters · 15h ago

SENIOR FDA OFFICIAL SAYS KENNEDY WAS NOT INVOLVED IN ANY ASPECT OF THE MODERNA PRODUCT- PRESS CALL

Reuters · 15h ago

SENIOR FDA OFFICIAL SAYS FDA COULD CONSIDER MODERNA'S FLU SHOT FOR AGES 50-65 IF IT AMENDS ITS APPLICATION- PRESS CALL

Reuters · 15h ago

SENIOR FDA OFFICIAL SAYS SECRETARY ROBERT F KENNEDY JR HAS NOT BEEN INVOLVED IN VACCINE POLICY AT THE FDA - PRESS CALL

Reuters · 15h ago

Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case

Seeking Alpha · 15h ago

BUZZ-U.S. STOCKS ON THE MOVE-Micron, McDonald's, Generac

Reuters · 15h ago

Market Voices: U.S.-Mexico-Canada trade deal, Kraft Heinz, Moderna

Seeking Alpha · 16h ago

These Stocks Are Today's Movers: Shopify, Moderna, Robinhood, Unity, Vertiv, Generac, Beta Tech, Humana, T-Mobile, and More

Barron‘s · 16h ago

Midday Fly By: January payrolls jump, Ford reports mixed Q4

TipRanks · 17h ago

Stocks Slide as Robust Jobs Data Signals Fewer Fed Rate Cuts

NASDAQ · 17h ago

FDA’s vaccines chief reportedly overrules staffers to reject Moderna’s flu shot application

Seeking Alpha · 18h ago

Prasad overruled FDA scientists on Moderna application, STAT says

TipRanks · 18h ago

Webull provides a variety of real-time MRNA stock news. You can receive the latest news about Moderna through multiple platforms. This information may help you make smarter investment decisions.

About MRNA

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).